Skip to main content
. 2022 Jun 8;12:854973. doi: 10.3389/fonc.2022.854973

Table 1.

Mouse models of fusion genes.

Fusion Gene Year Expression Mechanism Phenotype References
RUNX1-RUNX1T1 2006 Constitutive Retrovirus 9a isoform: AML (37)
2001 Constitutive Germline - Mrp8 promoter (myeloid specific) AML, T-ALL after ENU treatment (38)
2013 Inducible Tet-On MDS (39)
2021 Inducible eR1-CreERT2 AML, MPD (40)
CBFB-MYH11 2006 Inducible Mx1-Cre AML (41)
KMT2A-MLLT3 1996 Constitutive Germline AML (42)
2000 Inducible Lmo2-Cre AML (43)
2013 Constitutive Retrovirus AML (Transduced LSKs > GMP) (44)
2016 Inducible Retrovirus AML (45)
MLL-PTD 2012 Constitutive Germline AML (if FLT3-ITD mutated) (46)
KMT2A-MLLT1 2013 Inducible CreER ALL (47)
2014 Inducible Tet-On ALL (48)
 NUP98-NSD1 2007 Constitutive Retrovirus AML (49)
2014 Constitutive Retrovirus AML (if FLT3-ITD mutated) (50)
2020 Constitutive Retrovirus AML (51)
Other NUP98 fusions 2020 Inducible Tet-On Retrovirus AML (52)
CBFA2T3-GLIS2 2019 Inducible Tet-On AML (53)
PML-RARA 1997 Constitutive Germline – Ctsg promoter (myeloid specific) AML – long latency (54)
1999 Constitutive Retrovirus Differentiation blockade, enhanced self-renewal (55)
2003 Constitutive Germline – Mrp8 promoter (myeloid specific) AML (56)

AML, acute myeloid leukemia; ENU, N-ethyl-N-nitrosurea; GMP, granulocyte-macrophage progenitor; ITD, internal tandem duplication; LSK, Lin-Sca1+Kit+; MDS, myelodysplastic syndrome; MPD, myeloproliferative disease; PTD, partial tandem duplication; T-ALL, T-acute lymphoblastic leukemia.